RxDoctor Payments Data

Nicole Grove, APRN

Family · Windham, NHNPI 1902401557

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,599 of the $2,480 with a category attached, or 64.5%. 10 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 35.5% of the total. Reporting peaked in 2021 at $1,321 and has fallen 90.7% since, to $123 in 2025. Among family clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,480in general payments, 2019–2025

Across 18 payments — averaging $137.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$881
  • Novo Nordisk$576
  • Amgen$490
  • Genentech USA, Inc.$124
  • Edwards Lifesciences$123
  • AbbVie$123
  • plus $163 from 4 others

What the payments were for

  • Consulting fees$80032%
  • Travel & lodging$813%
  • Food & beverage$1,59964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,480 in reported general payments places this provider in the 90th percentile of 713 family providers in New Hampshire.

See all family providers in New Hampshire

Medicare billing

Part B allowed, 2024
$59,793
Medicare patients
451
Services billed
1,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate28$758
Methylprednisolone94$638
Doxycycline Hyclate99$619
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav59$404
Mupirocin63$361
Azithromycin68$255
Fluticasone Propionate13$145
Cephalexin37$135
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim14$109
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$64
Prednisone24$31

Paid to pharmacies, not to this prescriber.

Other family in Windham

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →